IQVIA Launches AI-Powered Predictive Clinical Development
Research Triangle Park, North Carolina — September 3, 2026 IQVIA announced the launch of IQVIA Predictive Clinical Development, an...
Clinical Research
Advertisement
Fortrea to Acquire Worldwide Clinical Trials’ Early Phase Unit
DURHAM, N.C. and RESEARCH TRIANGLE PARK, N.C., September 2, 2026 Fortrea has entered into a definitive agreement to acquire...
RedHill Divests Talicia to Apotex for $18 Million
Miami, Florida, August 31, 2026 RedHill Biopharma Ltd. announced that it has entered into an agreement to divest Talicia®...
IDEAYA’s IDE849 Advances Toward Phase 3 in Lung Cancer
South San Francisco, California, August 31, 2026 IDEAYA Biosciences, Inc. announced the successful completion of a U.S. Food and...
Jazz Reports Survival Benefit for Ziihera in GEA
Dublin, Ireland, August 31, 2026 Jazz Pharmaceuticals plc announced positive topline results from the Phase 3 HERIZON-GEA-01 clinical trial,...
Advertisements
Bayer Reports Phase 3 PET Data in Cardiac Amyloidosis
Berlin, Germany, August 30, 2026 Bayer announced detailed results from the Phase 3 REVEAL study evaluating investigational PET radiotracer...
AskBio Advances Heart Failure Gene Therapy in Phase 2
Durham, North Carolina, August 29, 2026 AskBio Inc. presented baseline characteristics from its Phase 2 GenePHIT clinical trial evaluating...
Ascletis Starts Phase III Trial of Oral GLP-1 Drug
Hong Kong, China, August 30, 2026 Ascletis Pharma Inc. announced that the first participant has been dosed in its...
Moderna Wins FDA Approval for 2026-27 COVID Vaccines
Cambridge, Massachusetts, August 27, 2026 Moderna, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved supplemental...
Natera Partners With Susan G. Komen to Advance Breast Cancer Awareness
Austin, Texas – August 28, 2026 Natera, Inc. announced a new national partnership with Susan G. Komen to accelerate...
Advertisement
